Dr. Jessica Zdinak
Founder and Chief Research Officer
Applied Research and Analysis Company

Dr. Jessica Zdinak is Chief Research Officer at Applied Research and Analysis Company, a leading U.S.-based woman-owned behavioral science research organization. She received a Ph.D. In Social Psychology & Statistics and has dedicated her entire career to applying her expertise with a focus on improving the lives of others - whether through the federal government, academic settings, public health, and now tobacco harm reduction.

Dr. Zdinak now devotes her time leading a growing international team of scientists and executives at ARAC, where she focuses on bringing expertise in psychology, statistics, and behavior change to tobacco harm reduction and product market success. Their team approaches behavioral science and consumer research using a triangular method - focusing on the consumer, regulatory frameworks and their requirements, and rigorous scientific methods - all while focusing on achieving clients' business objectives.

Her scientific approach to research has proven successful through successful MRTP and PMT product authorizations across a variety of studies, including label and claim development and comprehension, human factors/usability testing, and clinical behavioral switching studies, actual use, TPPI, and post-market surveillance systems. Zdinak’s goal is to improve people's lives, whether that is one smoker at a time, or through the relationships she builds with colleagues, clients, family and friends.

Sessions with Dr. Jessica Zdinak

14:19 - 15:19
Product category, flavor, birthdates – are bans effective or simply creating new problems. Does legislating a ban get rid of a problem? Bans are being proposed around the world in innovative and traditional forms: phased illegalization based on date of birth, constriction of product attributes and sales channels, and, of course, outright prohibitions. Measures are gaining traction from one geography to another. But if we dive deeper, what is a ban, and what does it actually do? Bans are simple and easy to package to constituents: "Because of X, we are banning Y." Simple messaging often belies more complexity in an issue hiding below the surface. This panel explores that complexity from why bans come about, what's standardized and what's unique to them, and, most importantly, to their highly complex effects: incentivization of illicit markets to satisfy demand; economic impacts from resource diversion for enforcement to losses throughout the value chain; and frustration of overarching THR and wider public health goals tied to consumer demand shifts to illicit products, backsliding to less harm-reduced ones, and social costs of the "illicitization" of products.

Moderators

  • Dr. Jessica Zdinak

    Founder and Chief Research Officer, Applied Research and Analysis Company

Speakers